KIRIN

This brand name is authorized in Cyprus, Hong Kong

Active ingredients

The drug KIRIN contains one active pharmaceutical ingredient (API):

1 Spectinomycin UNII 93AKI1U6QF - SPECTINOMYCIN

Spectinomycin is an inhibitor of protein synthesis in the bacterial cell; the site of action is the 30S ribosomal subunit. Spectinomycin is indicated in the treatment of acute gonorrheal urethritis and proctitis in the male and acute gonorrheal cervicitis and proctitis in the female when due to susceptible strains of Neisseria gonorrhoeae. Read about Spectinomycin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
KIRIN Powder for suspension for injection	Υπουργείο Υγείας (CY)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01XX04	Spectinomycin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01X Other antibacterials → J01XX Other antibacterials
Discover more medicines within J01XX04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: HK	Department of Health Drug Office	Identifier(s): 35734, 36853